What are the leading stocks in the pharmaceutical sector?

What are the leading stocks in the pharmaceutical sector?

The leading stocks in the pharmaceutical sector refer to the stocks of listed companies with the largest market value and the strongest strength in the pharmaceutical industry. Pharmaceutical manufacturing, biotechnology, these companies, what are the leading stocks in the pharmaceutical sector brought by the following small series, which are of great benefit to you. Let's have a look.

What are the leading stocks in the pharmaceutical sector?

The leading stocks in the pharmaceutical industry are:

1, Shanghai Pharmaceutical 60 1607: One of the "Top Ten Most Influential Enterprises" in China pharmaceutical industry, with the circulation market value ranking first in the industry, 360. 65.438+07 billion yuan, with a P/E ratio of 654.38+065.438+0. 8 1;

2. Jiuzhoutong 600998: ranking of domestic private pharmaceutical business 1, ranking second in circulation market value industry, 220. 06 billion yuan, the price-earnings ratio reached 18. 86;

3. Yifeng Pharmacy 603939: Its main business is drug retail business, drug wholesale business and other business income, and its circulation market value ranks third, 2 19. 8.3 billion yuan, with a price-earnings ratio of 3.8. 80。

What are the leading stocks in the Chinese medicine sector?

What are the leading stocks of traditional Chinese medicine: Pien Tze Huang1; ② Yunnan Baiyao; 3 Jiuzhitang; ④ Tong Ren Tang; 5 Baiyun Mountain; 6 Jiang Zhong Pharmaceutical; 7 Ma Yinglong. In addition, Chinese medicine stocks include Neptune Bio, Fengyuan Pharmaceutical, Dong 'e Ejiao and Livzon Group. Since the implementation of the policy of "centralized procurement of the fifth batch of drugs" in the second half of last year, the CSI medicine index has been continuously adjusted back by more than 20%, and it has dropped by-14% in the dimension in the past year, while the CSI Chinese medicine index has been "outstanding", with an increase of nearly 40% in the past year, ranking first in the pharmaceutical sector. : 1, Tongrentang (600085): Chinese medicine leading stock. 1October 22nd 10, Tongrentang shares rose 0.6 1% to 33. 1 1 yuan; Within five days, the stock price fell by 1.06%, with a market value of 45.409 billion yuan.

After more than ten years of development, the company has now formed a relatively complete industrial chain with Chinese herbal medicine cultivation, Chinese patent medicine research and development, pharmaceutical logistics and distribution, and pharmaceutical retail as the core.

2. Baiyun Mountain (600332): Chinese medicine leading stock. 654381On October 22nd, the stock price of Baiyun Mountain fell by 0.5% in five days, and the increase since this year has reached 1.7 1%, with the latest price of 29.8 yuan and price-earnings ratio of 16.62.

The company is a Chinese medicine enterprise with the most complete variety, the largest number of Chinese time-honored brands and the largest output value in the domestic Chinese medicine industry. There are more than 400 kinds of traditional Chinese medicines, covering almost all the classifications of traditional Chinese medicines and 45 kinds of national second-class protected traditional Chinese medicines, among which more than 20 kinds are exclusively produced, and more than 0/00 kinds of foreign famous brand pharmaceutical products are exclusively represented. Such as Wang Laoji, Chen Liji, Pan Gaoshou, Jing Xiu Tang, etc. , are well-known century-old stores. Among them, there are 20 exclusive products such as Xiaoke Pill and Huatuo Zaizao Pill. Wang Laoji Herbal Tea, Baoji Pill, Wuji Baifeng Pill and other products are well-known products in South China and Southeast Asia. After five enterprises including Wang Laoji Pharmaceutical and Jingxiutang Pharmaceutical were selected as the first batch of "Chinese Time-honored Brands", three enterprises including Zhong Yi Pharmaceutical were selected as the second batch of "Chinese Time-honored Brands".

What are the leading stocks in the biomedical sector?

Biomedical plate is one of the hot industries in the current capital market, and many listed companies have strong competitiveness and performance.

Leading stocks mainly include: United Amino Acid, Hengrui Pharma, Yao Ming Bio, Mindray Medical, etc. These companies have high technical content and innovative ability in the fields of biopharmaceuticals, medical diagnosis and health services, and have broad market prospects. Investors can pay attention to these enterprises with leading potential and invest cautiously according to the actual situation.

What are the leading stocks of Chinese medicine stocks?

Chinese medicine leading stocks include Guangxin Pharmaceutical (3005 19), Angel Pharmaceutical (00210/8), Shenlong Rongfa (300534), Yunnan Baiyao (00538), Tongrentang (600085) and Pien Tze Huang.

Extended information:

1. Other Chinese medicine concept stocks include:

1. Taian Tang: In the past seven trading days, Taian Tang fell by 20.26%, with the highest price of 6.48 yuan, and the total market value fell by 85 1 10,000 yuan, a decrease of 20.26%.

2. Yisheng Pharmaceutical: Looking back on the past seven trading days, Yisheng Pharmaceutical has fallen for six consecutive days. The whole period fell by 9.38%, the highest price was 8.58 yuan, the lowest price was 9. 14 yuan, and * * * sold 40196,600 lots.

3. Yiling Pharmaceutical: The share price of Yiling Pharmaceutical fell 15.08% in recent 7 days, and rose by 2.26% in 2022, with the highest price of 25.76 yuan and the market value of 34.784 billion yuan.

What is the list of doctors' leading stocks?

The leading stocks of medical biology are: Hengrui Pharma (600276), Fosun Pharma (600 196), Yunnan Baiyao (000538), Xinlitai (00282 1) and Aier Ophthalmology (3000 15).

Stock name

stock code

Ownership board

industry category

Related reasons

Hengrui pharmacy

600276

Shanghai stock market

Chemical pharmacy

It is the pioneer and leader of innovative drug research and development in China. The company is a leading company in the field of innovative drugs in China, with a complete product structure and R&D channels. Leading the research and development of innovative drugs. Pirotinib is independently developed by the company 1. An innovative drug is the company's blockbuster product. The indication market of pirotinib for breast cancer is $65.438+$400 million, and its indication will be extended to lung cancer and gastric cancer in the future.